Become a Member
Dark Mode
Become a Member
Elections 2024
Elections Fact-Check
Compare Manifestos
Electoral Bonds
Manipur: A Year On
Uncovering Hate
'Trapped' in Russia
Members Only
Neon
More
FIT
Webqoof
My Report
Brand Studio
Indian Diaspora
Entertainment
Opinion
World
Videos
Podcasts
Sports
Law
More
Gender
Climate Change
FAQs
Explainers
Graphic Novels
Education
Quint Lab
Business
Good News
Members' Opinion
Photos
Dark Mode
Become a Member
Home
Elections
Jobs
About Us
T&C
Privacy Policy
BECOME A MEMBER
Created by potrace 1.16, written by Peter Selinger 2001-2019
FOLLOW US ON
About Us
Contact Us
Privacy Policy
ADVERTISEMENT
REMOVE AD
×
×
Pfizer BioNTech COVID Vaccine
Claim About Side Effects in Kids Who Got Pfizer’s COVID Vaccine Is Misleading!
Pfizer COVID Vaccine 80% Effective for Children Aged 5 and Below, Shows Data
ADVERTISEMENT
REMOVE AD
First Real World Study Shows 2 Doses of Vaccine Not Enough Against Omicron
Amid Omicron Fear, US Authorises COVID-19 Boosters For Teens : Report
Pfizer, Moderna COVID Vax Boosters Authorized for All Adults: US FDA
Third Pfizer Dose More Effective in Reducing Severe Covid: Study
Moderna, J&J COVID-19 Boosters Approved by US FDA
US Approves Pfizer’s Covid Booster for Elderly & High-Risk Adults
US FDA Advisory Limits COVID-19 Booster Doses to Those ‘At High Risk'
Pfizer COVID Vaccine Efficacy Drops to 47 Percent After 6 Months: Lancet
US Experts Divided Over Pfizer’s COVID Booster Application Ahead of Final Call
Blood Clot Risk Higher From COVID-19 Than After Vaccination: Study
Claim About Side Effects in Kids Who Got Pfizer’s COVID Vaccine Is Misleading!
Pfizer COVID Vaccine 80% Effective for Children Aged 5 and Below, Shows Data
First Real World Study Shows 2 Doses of Vaccine Not Enough Against Omicron
Amid Omicron Fear, US Authorises COVID-19 Boosters For Teens : Report
Pfizer, Moderna COVID Vax Boosters Authorized for All Adults: US FDA
Third Pfizer Dose More Effective in Reducing Severe Covid: Study
Moderna, J&J COVID-19 Boosters Approved by US FDA
Pfizer COVID Vaccine Efficacy Drops to 47 Percent After 6 Months: Lancet
US Approves Pfizer’s Covid Booster for Elderly & High-Risk Adults
US FDA Advisory Limits COVID-19 Booster Doses to Those ‘At High Risk'
US Experts Divided Over Pfizer’s COVID Booster Application Ahead of Final Call
Blood Clot Risk Higher From COVID-19 Than After Vaccination: Study
Load More